What as‑needed anxiolytic is appropriate for an adult with major depressive disorder, anorexia nervosa, binge‑drinking behavior, latent tuberculosis infection, and elevated liver enzymes?

As-Needed Anxiolytic for Complex Medical and Psychiatric Comorbidities

In this patient with major depressive disorder, anorexia nervosa, binge drinking, latent TB infection, and elevated liver enzymes, hydroxyzine (an antihistamine with anxiolytic properties) is the safest as-needed option, avoiding benzodiazepines entirely due to the high risk of worsening alcohol use disorder and hepatotoxicity.

Clinical Reasoning

Why Benzodiazepines Are Contraindicated

The guidelines consistently warn about benzodiazepine risks, but your patient has three absolute contraindications:

• Severe liver disease: Benzodiazepines are explicitly cautioned against in patients with hepatic impairment 1. Your patient's elevated liver enzymes—whether from starvation-induced autophagy (common in anorexia nervosa 2, 3) or alcohol use—make benzodiazepines dangerous due to impaired metabolism and increased sedation risk.

• Substance use disorder: The patient's binge drinking behavior represents active alcohol use disorder. Guidelines explicitly state benzodiazepines carry "increased risk of abuse and dependence" and should be "time limited" 4. Combining benzodiazepines with alcohol use creates dangerous synergistic CNS depression and accelerates addiction pathways 1.

• Anorexia nervosa: Patients with eating disorders and substance use disorders are specifically excluded from anxiety disorder treatment guidelines 5, recognizing that standard anxiolytic approaches require modification in these populations.

The Hepatic Consideration

Your patient's elevated liver enzymes require careful interpretation:

• In anorexia nervosa, transaminase elevations often reflect starvation-induced hepatocyte autophagy rather than intrinsic liver disease 2, 3
• However, this distinction doesn't change prescribing safety—hepatically metabolized medications remain high-risk
• The latent TB infection adds complexity: if isoniazid prophylaxis is initiated, it carries significant hepatotoxicity risk 6, making additional hepatotoxic medications even more problematic

Recommended Approach: Hydroxyzine

Hydroxyzine 25-50 mg orally as needed (maximum 100 mg/day) offers:

• No abuse potential: Critical given the alcohol use disorder
• Minimal hepatic risk: Safer metabolic profile than benzodiazepines
• Effective anxiolysis: Antihistaminic mechanism provides genuine anxiety relief for acute episodes
• Sedating properties: Can address both anxiety and potential insomnia without benzodiazepine risks

Dosing specifics: Start with 25 mg as needed; may increase to 50 mg per dose if inadequate response. Limit to 2-3 doses daily maximum. Warn about drowsiness and avoid driving for 4-6 hours after dosing.

Alternative: Buspirone (If Scheduled Dosing Acceptable)

If the patient needs more regular anxiety management rather than true "as-needed" dosing:

• Buspirone 5 mg twice daily, titrating to 10-15 mg twice daily over 2-4 weeks 7
• Takes 2-4 weeks for full effect, so not suitable for acute PRN use
• No abuse potential, no hepatotoxicity, no interaction with alcohol
• Useful for generalized anxiety in the context of depression 8, 9

What About SSRIs for the Depression?

The guidelines strongly recommend treating the underlying major depressive disorder with either cognitive behavioral therapy or second-generation antidepressants 10, 11. For this patient:

• Sertraline or escitalopram would be first-line choices—both treat comorbid anxiety and depression 11, 12
• These have lower drug interaction profiles than other SSRIs 7, important given potential TB treatment
• Start low (sertraline 25 mg or escitalopram 5 mg daily) given anorexia nervosa and hepatic concerns
• Monitor liver enzymes closely during titration

However, SSRIs take 4-8 weeks for anxiolytic effects 11, necessitating the separate as-needed strategy above.

Critical Pitfalls to Avoid

1. Do not prescribe lorazepam or other benzodiazepines despite their common use for anxiety 13, 7, 1. The combination of liver dysfunction, alcohol use, and eating disorder makes this dangerous.

2. Do not assume liver enzymes will normalize quickly. In anorexia nervosa with refeeding, transaminases may initially worsen before improving 2, 3. This is expected with starvation-induced autophagy and should not trigger medication discontinuation if nutritional rehabilitation continues.

3. Screen for suicidality regularly. Anxious depression carries higher suicide risk 9, and this patient has multiple risk factors (eating disorder, substance use, depression).

4. Address the alcohol use directly. The binge drinking requires concurrent treatment—consider referral to addiction services. Treating anxiety alone without addressing alcohol use will fail.

5. Coordinate with TB treatment if initiated. Isoniazid prophylaxis for LTBI adds hepatotoxicity risk 6. Monthly liver enzyme monitoring becomes mandatory if isoniazid is started, and the threshold for stopping hepatotoxic medications drops significantly.

Monitoring Plan

• Liver enzymes: Check monthly initially, especially if TB prophylaxis starts
• Weight and nutritional status: Weekly weights; coordinate with eating disorder treatment team
• Anxiety symptoms: Use GAD-7 or similar tool every 2-4 weeks to assess response
• Alcohol use: Quantify drinks per week at each visit; consider AUDIT-C screening
• Medication response: Reassess hydroxyzine efficacy at 2 weeks; if inadequate, consider buspirone transition rather than dose escalation